[Role of prognostic factors in evaluation of survival in breast cancer].
The aim of our study is to evaluate the prognostic value of tumor size, regional lymph nodes and steroid-hormones receptors status, histological grade, and the presence of metastasis in other organs. Our retro-prospective study analyzes a group of 266 patients diagnosed and treated for breast cancer in the IVth Obstetrics and Gynecology Clinic. 150 of the patients (56.7%) presented stage I disease, and only 39 (14.7%) stage IV. 151 (57%) of the patients had no regional lymph nodes metastasis and 252 (94.9%) were free of metastatic disease when they first presented for diagnosis. Almost 43% of all tumors were poorly differentiated. In the majority of cases, the tumors were positive for steroid receptors. The survival rate after 5 years was higher in the absence of lymph nodes metastasis (76%) and the presence of a low Nottingham prognostic index (78%). The identification and evaluation of prognostic factors is an essential step for treatment planning and limiting metastatic disease.